Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Dow
Medtronic
Merck
Moodys

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Basiliximab - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for basiliximab
Tradenames:1
Patents:112
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for basiliximab
Recent Clinical Trials for basiliximab

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Fady M Kaldas, M.D., F.A.C.S.Phase 4
The Affiliated Hospital Of Guizhou Medical UniversityPhase 4
Hainan General HospitalPhase 4

See all basiliximab clinical trials

Patent Text Search: US Patents for basiliximab

These patents were identified by searching patent claims

Supplementary Protection Certificates for basiliximab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2016000049 Germany   Start Trial PRODUCT NAME: RITUXIMAB UND REKOMBINANTE HUMANE HYALURONIDASE; NAT. REGISTRATION NO/DATE: EU/1/98/067/003 20140321; FIRST REGISTRATION: EU EU/1/98/067/003 20140621
780 Luxembourg   Start Trial PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826
1248802/01 Switzerland   Start Trial PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: SWISSMEDIC 61521 15.12.2011
2015031 Lithuania   Start Trial PRODUCT NAME: TRASTUZUMABAS IR REKOMBINANTINE ZMOGAUS HIALURONIDAZE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
C0053 France   Start Trial PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617
2011014 Lithuania   Start Trial PRODUCT NAME: BELATACEPTUM; REGISTRATION NO/DATE: EU/1/11/694/001, 2011 06 17 EU/1/11/694/002 20110617
902 Luxembourg   Start Trial 91902, EXPIRES: 20260523
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
AstraZeneca
McKesson
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.